For over 115 years the American Lung Association has focused on driving excellence and innovation through research. Today, we continue to support trailblazing research, novel ideas and innovative approaches with the hope of eliminating lung disease and improving life for those living with lung disease. Together, we are investing in brilliant scientific minds of the future and supporting science with the potential to improve prevention, detection and treatment options.
Recent Funding Opportunities:
New cycle updates will be available July 2022
- Allergic Respiratory Diseases Award: $75,000 per year for up to two years
A long-standing joint effort between the American Lung Association and the American Academy of Allergy, Asthma & Immunology to encourage and support early-stage investigators with a primary faculty appointment in an allergy/immunology division or section, to conduct research into advancing the understanding of allergic respiratory disease.
- Innovation Award:$75,000 per year for up to two years
This award will support promising independent investigators who are leveraging their existing body of work to conduct basic science, behavioral, clinical, or translational research for lung health.
- Catalyst Award:$50,000 per year for up to two years
This award champions the next generation of scientists who are ascending toward independence by supporting mentored-investigators who are conducting basic science, behavioral, clinical or translational research into lung health.
- Public Policy Research Award:$50,000 per year for up to two years
This mechanism is designed to help stimulate and inform important public policy debates around healthy air and lung disease. This award supports research on and evaluation of existing public policy and programs, as well as projects that inject innovative ideas into public policies impacting lung health.
- Dalsemer Award:$50,000 per year for up to two years
This is a mentored award meant to provide seed monies to junior investigators for researching the mechanisms and biology of interstitial lung disease.
- COVID-19 & Respiratory Virus Research Award
$100,000 per year for up to two years
This award is intended to support investigators who have the ability to advance our knowledge of COVID-19 and other novel respiratory viruses with pandemic potential. Successful applicants have evidence of ongoing excellence and productivity in a related field. A Letter of Intent (LOI) is required for this award. The LOI deadline has passed.
- Lung Cancer Discovery Award: $100,000 per year for up to two years
Intended to support independent investigators conducting clinical, laboratory, epidemiological or any groundbreaking project aimed at revolutionizing our current understanding of lung cancer and improving diagnostic, clinical and treatment methods. A Letter of Intent (LOI) is required for this award. The LOI deadline has passed.
- ALA/ATS/CHEST Foundation Respiratory Health Equity Research Award $100,000 per year for up to two years
A new joint effort between the American Lung Association, ATS and the CHEST Foundation supports clinical research to improve outcomes in preventing and/or treating lung diseases that disproportionately affect under-represented minority patient groups. The effort will support two $100,000 grants. One awarded grant is intended to support investigators that will address topics on improving clinical outcomes in preventing and/or treating lung disease in groups disproportionately impacted. The second awarded grant is intended to support an investigator who is a person of color that is doing clinical research in a pulmonary disease that disproportionately affects communities of color. A Letter of Intent deadline has passed.
Award Terms and Conditions
Learn more about the Terms and Conditions governing our Awards and Grants Program.
It is strongly recommended that applicants thoroughly read the Program Descriptions and Terms and Conditions to determine eligibility and to ensure accurate preparation of an application.
Application materials are available through proposal CENTRAL.
Anticipated Research Timeline
- July 1: New research term begins
- August: New award cycles announced; applications available through proposalCENTRAL
- Early Fall: September 23, 2021- Lung Cancer Discovery Award and COVID -19 Award letters of intent (LOI) due
- Late Fall: November 8, 2021- All LOI outcome notifications emailed to all applicants
- December 16, 2021: All applications are due through proposalCENTRAL
- January-April: Administrative review and scientific peer review
- June: Outcome notifications emailed to all applicants
- June 30: Research term ends
While eligibility varies by award type, the following requirements apply to all awards:
- Candidates must be U.S. citizens or foreign nationals holding one of the following visa immigration statuses:
- permanent resident (Green Card),
- exchange visitor (J-1),
- temporary worker in a specialty occupation (H-1B),
- Canadian or Mexican citizen engaging in professional activities (TN),
- Australians in Specialty Occupation (E-3 visa)
- temporary worker with extraordinary abilities in the sciences (O-1)
- Candidates must be employed by a U.S. not-for-profit institution.
- Candidates are only allowed to submit 1 application per review cycle. Applicants who apply for more than one grant or award will forfeit any chance of funding.
Applicants deemed ineligible for a particular award, or who do not follow the instructions provided, may be disqualified.
Answers to frequently asked questions about our Awards & Grants.
Technical questions: contact proposal CENTRAL at [email protected] or 1-800-875-2562.
Questions on the Awards and Grants program: email [email protected].
Page last updated: January 28, 2022